Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice
- PMID: 21694816
- PMCID: PMC3105633
- DOI: 10.1177/1756285611403646
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice
Abstract
As more investigations into factors affecting the quality of life of patients with multiple sclerosis (MS) are undertaken, it is becoming increasingly apparent that certain comorbidities and associated symptoms commonly found in these patients differ in incidence, pathophysiology and other factors compared with the general population. Many of these MS-related symptoms are frequently ignored in assessments of disease status and are often not considered to be associated with the disease. Research into how such comorbidities and symptoms can be diagnosed and treated within the MS population is lacking. This information gap adds further complexity to disease management and represents an unmet need in MS, particularly as early recognition and treatment of these conditions can improve patient outcomes. In this manuscript, we sought to review the literature on the comorbidities and symptoms of MS and to summarize the evidence for treatments that have been or may be used to alleviate them.
Keywords: clinical medicine; comorbidity; multiple sclerosis; neurology; review; signs and symptoms; therapy.
Figures
![Figure 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0750/3105633/eb790d1351a8/10.1177_1756285611403646-fig1.gif)
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Comorbidity in Multiple Sclerosis.Front Neurol. 2020 Aug 21;11:851. doi: 10.3389/fneur.2020.00851. eCollection 2020. Front Neurol. 2020. PMID: 32973654 Free PMC article. Review.
-
Management of Multiple Sclerosis Symptoms and Comorbidities.Continuum (Minneap Minn). 2019 Jun;25(3):753-772. doi: 10.1212/CON.0000000000000732. Continuum (Minneap Minn). 2019. PMID: 31162315 Review.
-
Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms.J Neurol. 2021 Feb;268(2):559-568. doi: 10.1007/s00415-020-10192-z. Epub 2020 Sep 2. J Neurol. 2021. PMID: 32876720
-
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.Expert Rev Neurother. 2013 Dec;13(12 Suppl):55-9. doi: 10.1586/14737175.2013.865880. Expert Rev Neurother. 2013. PMID: 24289845 Review.
Cited by
-
Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management.Nutrients. 2024 Sep 5;16(17):2996. doi: 10.3390/nu16172996. Nutrients. 2024. PMID: 39275311 Free PMC article. Review.
-
Neurorehabilitation in Multiple Sclerosis-A Review of Present Approaches and Future Considerations.J Clin Med. 2022 Nov 27;11(23):7003. doi: 10.3390/jcm11237003. J Clin Med. 2022. PMID: 36498578 Free PMC article. Review.
-
Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist.Noro Psikiyatr Ars. 2017 Dec;54(4):328-333. doi: 10.5152/npa.2016.16976. Epub 2016 Apr 26. Noro Psikiyatr Ars. 2017. PMID: 29321706 Free PMC article.
-
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).J Neurol. 2014 Jan;261(1):1-16. doi: 10.1007/s00415-013-7169-7. Epub 2013 Nov 23. J Neurol. 2014. PMID: 24272588 Free PMC article. Review.
-
Biomechanical analysis of spasticity treatment in patients with multiple sclerosis.Ther Adv Neurol Disord. 2015 Sep;8(5):203-11. doi: 10.1177/1756285615601390. Ther Adv Neurol Disord. 2015. PMID: 26668586 Free PMC article.
References
-
- Abraham S., Scheinberg L.C., Smith C.R., LaRocca N.G. (1997) Neurologic impairment and disability status in outpatients with multiple sclerosis reporting dysphagia symptomatology. Neurorehabil Neural Repair 11: 7–13
-
- Albrecht H., Schwecht M., Pollmann W., Parag D., Erasmus L.P., Konig N. (1998) Local ice application in therapy of kinetic limb ataxia. Clinical assessment of positive treatment effects in patients with multiple sclerosis. Nervenarzt 69: 1066–1073 - PubMed
-
- Alusi S.H., Worthington J., Glickman S., Bain P.G. (2001) A study of tremor in multiple sclerosis. Brain 124: 720–730 - PubMed
-
- Amato M.P., Portaccio E., Goretti B., Zipoli V., Battaglini M., Bartolozzi M.L., et al. (2007) Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol 64: 1157–1161 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous